Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited’s Net Profit Rose 5% in First Three Quarters of 2022

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (广州白云山医药集团股份有限公司) (600332.SH) reported a net profit of 3.7 billion yuan in the first three quarters of 2022, up 5% year-on-year.

Meanwhile, the company posted 54.8 billion yuan in revenue, up 2.4% year-on-year.

At the end of the reporting period, it had 69.6 billion yuan in total assets and 35.7 billion yuan in total liabilities, with a liability-to-asset ratio of 51.3%.